Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EyePoint Pharmaceuticals, Inc. Director's Dealing 2018

Mar 30, 2018

32254_dirs_2018-03-30_08664850-9d11-41cc-8fa7-07c974b01349.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2018-03-28

Reporting Person: Eastman Ronald W (Director, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8606324 Indirect

Footnotes

F1: The shares are held by EW Healthcare Partners L.P. ("EWHP") and EW Healthcare Partners-A L.P. ("EWHP-A"). The reporting person is a manager of the entity that is the general partner of the general partner of EWHP and EWHP-A, which own the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.